Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Phosphoinositide-3-kinase inhibitors: evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511Brian A Lanman, Anthony B Reed, Victor J Cee, et al.Journal of Medicinal Chemistry|September 27, 2008
3-amino-7-phthalazinylbenzoisoxazoles as a novel class of potent, selective, and orally available inhibitors of p38alpha mitogen-activated protein kinaseLiping H Pettus, Shimin Xu, Guo-Qiang Cao, et al.Journal of Medicinal Chemistry|September 27, 2008
Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffoldBrad Herberich, Guo-Qiang Cao, Partha P Chakrabarti, et al.Bioorganic & Medicinal Chemistry Letters|October 23, 2016
Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitorsRyan P Wurz, Christine Sastri, Derin C D'Amico, et al.Bioorganic & Medicinal Chemistry Letters|January 21, 2015
The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitorsRyan P Wurz, Liping H Pettus, Claire Jackson, et al.ACS Medicinal Chemistry Letters|April 21, 2016
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase InhibitorsVictor J Cee, Frank Chavez, Bradley Herberich, et al.ACS Medicinal Chemistry Letters|September 19, 2019
Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12CYoungsook Shin, Joon Won Jeong, Ryan P Wurz, et al.Journal of Medicinal Chemistry|June 11, 2016
Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase InhibitorsLiping H Pettus, Kristin L Andrews, Shon K Booker, et al.Journal of Medicinal Chemistry|January 10, 2019
Discovery of ( R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4- b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3 H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological MalignanciesHui-Ling Wang, Kristin L Andrews, Shon K Booker, et al.ACS Medicinal Chemistry Letters|September 24, 2015
Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) InhibitorsRyan P Wurz, Liping H Pettus, Kate Ashton, et al.Pageof 4